Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2009-04-02 | Max E. Link 68 Chairman, Director III The following table sets forth the cash and noncash compensation paid to the Company's directors for the year ended December 31, 2008: Max E. Link 57,500 — 72,431 129,931 Members of the Audit Committee Gregory Weaver Max E. Link Augustine Chow The Audit Committee's principal responsibilities are to review financial statements and reports filed by the Company with the SEC, select annually a firm of independent accountants to conduct the annual audit of the Company's financial statements, assess the independence of the Company's independent auditors and meet with the independent auditors from time to time in order to review the Company's general policies and procedures with respect to audits, accounting and financial controls. Mr. Weaver (Chairman) and Drs. Link and Chow, each of whom is independent under the applicable rules of The NASDAQ Stock Market ("NASDAQ") and Rule 10A-3 under the Exchange Act currently serve on the Audit Committee. The Compensation Committee is responsible for establishing and administering the compensation policies applicable to the Company's directors, officers and key personnel, for recommending compensation arrangements to the Board of Directors and for evaluating the performance of senior management. Drs. Pace (Chairman) and Link and Mr. Weaver currently comprise the Compensation Committee. The Nominating and Governance Committee is responsible for identifying and recruiting new members of the Board of Directors when vacancies arise, identifying and recruiting nominees for election as directors, reconsideration of incumbent directors in connection with nominations for elections of directors and ensuring that the Board of Directors is properly constituted to meet its corporate governance obligations. The current members of the Nominating and Governance Committee are Drs. Pace and Link. |
| 2010-04-30 | Max E. Link 69 Chairman, Director III The Board of Directors has nominated Dr. Max E. Link ... Dr. Link has served as a director of the Company since 1997 and has been the Chairman of the Board of Directors since October 2001. The Board of Directors concluded that Dr. Link should be nominated to continue to serve as a director on account of, among other things, the following experience, qualifications, attributes, and skills: - Leadership attributes, including experience serving as a director on the boards of several companies - Experience in the pharmaceutical and biotechnology industries - Professional and educational background Committees: - Audit Committee (Chairman) - Compensation Committee - Nominating and Governance Committee 2009 Director Compensation Table: Max E. Link: Fees Earned or Paid in Cash: $54,800, Option Awards: $61,250, Total: $116,050 Audit Committee members: Mr. Weaver (Chairman), Drs. Link and Chow Compensation Committee members: Drs. Pace (Chairman) and Link and Mr. Weaver Nominating and Governance Committee members: Drs. Pace and Link |
| 2014-04-30 | Max E. Link, Ph.D. 73 Chairman, Director III The Audit Committee consists of Dr. Max Link, Chairman, Dr. Augustine Chow and Mr. Frederick J. Fritz. Mr. Hooper (Chairman) and Drs. Link and Martinez currently comprise the Compensation Committee. The current members of the Nominating and Governance Committee are Dr. Link (Chairman) and Dr. Martinez. 2013 Director Compensation Table: Max E. Link total $96,600. |
Data sourced from SEC filings. Last updated: 2025-08-30